Clinical Trial Update: Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™ [Phase 2]

View source ↗

Summary

Phase 2 efficacy study evaluating antimicrobial effectiveness of ZuraPrep for surgical site infections was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Surgical Site Infection

Drugs mentioned

• ZuraPrep

Snippet

Sponsor: Zurex Pharma, Inc. | Conditions: Surgical Site Infection | Phase 2 | Status: TERMINATED